How personal loss and hope drove Elaine Maynard’s work in clinical trials and patient-centric technologies

Citius Pharma receives FDA approval for immunotherapy targeting rare blood cancer

Halda Therapeutics raises $126M to take 'hold and kill' precision cancer drugs to the clinic

Gilead gains accelerated FDA approval for rare liver disease treatment

FDA lifts hold on BioNTech and MediLink's ADC trial After safety revisions

Breakthrough delivery system could transform Alzheimer’s treatment

First bispecific CAR-T therapy for MS receives green light from FDA to start phase 1

Breaking News: Lecanemab approved in UK but unavailable on NHS

Highlights

array(40) {
  [0]=>
  string(4) "8947"
  ["article_id"]=>
  string(4) "8947"
  [1]=>
  string(77) "FDA relaxes rules for companies manufacturing thermometers and infusion pumps"
  ["article_title"]=>
  string(77) "FDA relaxes rules for companies manufacturing thermometers and infusion pumps"
  [2]=>
  string(145) "The Food and Drug Administration (FDA) has released relaxed guidelines for infusion pumps and clinical thermometers due to the Covid-19 pandemic."
  ["short_description"]=>
  string(145) "The Food and Drug Administration (FDA) has released relaxed guidelines for infusion pumps and clinical thermometers due to the Covid-19 pandemic."
  [3]=>
  string(145) "The Food and Drug Administration (FDA) has released relaxed guidelines for infusion pumps and clinical thermometers due to the Covid-19 pandemic."
  ["description"]=>
  string(145) "The Food and Drug Administration (FDA) has released relaxed guidelines for infusion pumps and clinical thermometers due to the Covid-19 pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(115) "https://www.medicalplasticsnews.com/mpn-north-america/fda-relaxes-rules-for-companies-manufacturing-thermometers-a/"
  ["blog_url"]=>
  string(115) "https://www.medicalplasticsnews.com/mpn-north-america/fda-relaxes-rules-for-companies-manufacturing-thermometers-a/"
  [15]=>
  string(19) "2020-04-07 20:06:09"
  ["add_date"]=>
  string(19) "2020-04-07 20:06:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

FDA relaxes rules for companies manufacturing thermometers and infusion pumps

The Food and Drug Administration (FDA) has released relaxed guidelines for infusion pumps and clinical thermometers due 

array(40) {
  [0]=>
  string(4) "8850"
  ["article_id"]=>
  string(4) "8850"
  [1]=>
  string(45) "Notice to convene Annual General Meeting 2020"
  ["article_title"]=>
  string(45) "Notice to convene Annual General Meeting 2020"
  [2]=>
  string(100) "Indkaldelse til Ordinær Generalforsamling 2020 Notice to convene Annual General Meeting 2020  "
  ["short_description"]=>
  string(100) "Indkaldelse til Ordinær Generalforsamling 2020 Notice to convene Annual General Meeting 2020  "
  [3]=>
  string(173) "
Indkaldelse til Ordinær Generalforsamling 2020
 Notice to convene Annual General Meeting 2020
  
"
  ["description"]=>
  string(173) "
Indkaldelse til Ordinær Generalforsamling 2020
 Notice to convene Annual General Meeting 2020
  
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(116) "http://www.globenewswire.com/news-release/2020/04/07/2012720/0/en/Notice-to-convene-Annual-General-Meeting-2020.html"
  ["blog_url"]=>
  string(116) "http://www.globenewswire.com/news-release/2020/04/07/2012720/0/en/Notice-to-convene-Annual-General-Meeting-2020.html"
  [15]=>
  string(19) "2020-04-07 19:00:00"
  ["add_date"]=>
  string(19) "2020-04-07 19:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Notice to convene Annual General Meeting 2020

Indkaldelse til Ordinær Generalforsamling 2020
Notice to convene Annual Gen

array(40) {
  [0]=>
  string(4) "8948"
  ["article_id"]=>
  string(4) "8948"
  [1]=>
  string(31) "EU MDR: A last minute checklist"
  ["article_title"]=>
  string(31) "EU MDR: A last minute checklist"
  [2]=>
  string(150) "With the deadline for EU Medical Device Regulations (MDR) rapidly approaching, Nigel Flowers, managing director at injection moulding machinery suppli"
  ["short_description"]=>
  string(150) "With the deadline for EU Medical Device Regulations (MDR) rapidly approaching, Nigel Flowers, managing director at injection moulding machinery suppli"
  [3]=>
  string(235) "With the deadline for EU Medical Device Regulations (MDR) rapidly approaching, Nigel Flowers, managing director at injection moulding machinery supplier, Sumitomo (SHI) Demag UK, answers some common questions to help put minds at rest."
  ["description"]=>
  string(235) "With the deadline for EU Medical Device Regulations (MDR) rapidly approaching, Nigel Flowers, managing director at injection moulding machinery supplier, Sumitomo (SHI) Demag UK, answers some common questions to help put minds at rest."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(72) "https://www.medicalplasticsnews.com/news/eu-mdr-a-last-minute-checklist/"
  ["blog_url"]=>
  string(72) "https://www.medicalplasticsnews.com/news/eu-mdr-a-last-minute-checklist/"
  [15]=>
  string(19) "2020-04-07 18:02:06"
  ["add_date"]=>
  string(19) "2020-04-07 18:02:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

EU MDR: A last minute checklist

With the deadline for EU Medical Device Regulations (MDR) rapidly approaching, Nigel Flowers, managing director at injec

array(40) {
  [0]=>
  string(4) "8758"
  ["article_id"]=>
  string(4) "8758"
  [1]=>
  string(62) "GSK links with Vir Biotechnology to find coronavirus solutions"
  ["article_title"]=>
  string(62) "GSK links with Vir Biotechnology to find coronavirus solutions"
  [2]=>
  string(47) "GSK has bought a $250 million stake in the firm"
  ["short_description"]=>
  string(47) "GSK has bought a $250 million stake in the firm"
  [3]=>
  string(47) "GSK has bought a $250 million stake in the firm"
  ["description"]=>
  string(47) "GSK has bought a $250 million stake in the firm"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(102) "http://www.pharmatimes.com/news/gsk_links_with_vir_biotechnology_to_find_coronavirus_solutions_1337857"
  ["blog_url"]=>
  string(102) "http://www.pharmatimes.com/news/gsk_links_with_vir_biotechnology_to_find_coronavirus_solutions_1337857"
  [15]=>
  string(19) "2020-04-07 17:11:41"
  ["add_date"]=>
  string(19) "2020-04-07 17:11:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:37"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:37"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

GSK links with Vir Biotechnology to find coronavirus solutions

GSK has bought a $250 million stake in the firm

array(40) {
  [0]=>
  string(4) "8949"
  ["article_id"]=>
  string(4) "8949"
  [1]=>
  string(86) "It's a date: Medilink UK Healthcare Business Awards and Med-Tech Innovation Awards"
  ["article_title"]=>
  string(86) "It's a date: Medilink UK Healthcare Business Awards and Med-Tech Innovation Awards"
  [2]=>
  string(155) "This year’s Medilink UK Healthcare Business Awards, once again taking place alongside Med-Tech Innovation Expo, will celebrate the best-in-class tal"
  ["short_description"]=>
  string(155) "This year’s Medilink UK Healthcare Business Awards, once again taking place alongside Med-Tech Innovation Expo, will celebrate the best-in-class tal"
  [3]=>
  string(257) "This year’s Medilink UK Healthcare Business Awards, once again taking place alongside Med-Tech Innovation Expo, will celebrate the best-in-class talent and innovation from across the sector. The awards ceremony will take place on 28th September 2020."
  ["description"]=>
  string(257) "This year’s Medilink UK Healthcare Business Awards, once again taking place alongside Med-Tech Innovation Expo, will celebrate the best-in-class talent and innovation from across the sector. The awards ceremony will take place on 28th September 2020."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/it-s-a-date-medilink-uk-healthcare-business-awards-and-med-t/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/it-s-a-date-medilink-uk-healthcare-business-awards-and-med-t/"
  [15]=>
  string(19) "2020-04-07 16:56:01"
  ["add_date"]=>
  string(19) "2020-04-07 16:56:01"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

It's a date: Medilink UK Healthcare Business Awards and Med-Tech Innovation Awards

This year’s Medilink UK Healthcare Business Awards, once again taking place alongside Med-Tech Innovation Expo, w

array(40) {
  [0]=>
  string(4) "8799"
  ["article_id"]=>
  string(4) "8799"
  [1]=>
  string(95) "Patients with mild cases of COVID-19 may shed virus for up to eight days after symptoms resolve"
  ["article_title"]=>
  string(95) "Patients with mild cases of COVID-19 may shed virus for up to eight days after symptoms resolve"
  [2]=>
  string(158) "Half of people with mild symptoms of COVID-19 remained “viral positive” after their condition resolved, a small study from a Beijing hospital has "
  ["short_description"]=>
  string(158) "Half of people with mild symptoms of COVID-19 remained “viral positive” after their condition resolved, a small study from a Beijing hospital has "
  [3]=>
  string(168) "Half of people with mild symptoms of COVID-19 remained “viral positive” after their condition resolved, a small study from a Beijing hospital has suggested."
  ["description"]=>
  string(168) "Half of people with mild symptoms of COVID-19 remained “viral positive” after their condition resolved, a small study from a Beijing hospital has suggested."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(187) "https://www.pharmaceutical-journal.com/news-and-analysis/research-briefing/patients-with-mild-cases-of-covid-19-may-shed-virus-for-up-to-eight-days-after-symptoms-resolve/20207876.article"
  ["blog_url"]=>
  string(187) "https://www.pharmaceutical-journal.com/news-and-analysis/research-briefing/patients-with-mild-cases-of-covid-19-may-shed-virus-for-up-to-eight-days-after-symptoms-resolve/20207876.article"
  [15]=>
  string(19) "2020-04-07 16:46:00"
  ["add_date"]=>
  string(19) "2020-04-07 16:46:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Patients with mild cases of COVID-19 may shed virus for up to eight days after symptoms re

Half of people with mild symptoms of COVID-19 remained “viral positive” after their condition resolved, a sm

array(40) {
  [0]=>
  string(4) "8811"
  ["article_id"]=>
  string(4) "8811"
  [1]=>
  string(126) "Relief Therapeutics' Drug Aviptadil Enters FDA Trial at University of Miami to Treat COVID-19-Induced Respiratory Distress"
  ["article_title"]=>
  string(126) "Relief Therapeutics' Drug Aviptadil Enters FDA Trial at University of Miami to Treat COVID-19-Induced Respiratory Distress"
  [2]=>
  string(150) "Geneva, Switzerland: April 7, 2020: -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its drug Aviptadil has now entered"
  ["short_description"]=>
  string(150) "Geneva, Switzerland: April 7, 2020: -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its drug Aviptadil has now entered"
  [3]=>
  string(247) "Geneva, Switzerland: April 7, 2020: -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its drug Aviptadil has now entered FDA clinical trials at the University of Miami Miller School of Medicine for the treatment of..."
  ["description"]=>
  string(247) "Geneva, Switzerland: April 7, 2020: -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its drug Aviptadil has now entered FDA clinical trials at the University of Miami Miller School of Medicine for the treatment of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/relief-therapeutics-aviptadil-enters-fda-trial-university-miami-covid-19-induced-respiratory-18516.html?utm_source=ddc&utm_medium=rss&utm_campaign=Relief+Therapeutics%27+Drug+Aviptadil+Enters+FDA+Trial+at+University+of+Miami+to+Treat+COVID-19-Induced+Respiratory"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/relief-therapeutics-aviptadil-enters-fda-trial-university-miami-covid-19-induced-respiratory-18516.html?utm_source=ddc&utm_medium=rss&utm_campaign=Relief+Therapeutics%27+Drug+Aviptadil+Enters+FDA+Trial+at+University+of+Miami+to+Treat+COVID-19-Induced+Respiratory"
  [15]=>
  string(19) "2020-04-07 13:04:35"
  ["add_date"]=>
  string(19) "2020-04-07 13:04:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Relief Therapeutics' Drug Aviptadil Enters FDA Trial at University of Miami to Treat C

Geneva, Switzerland: April 7, 2020: -- RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” announces that its 

array(40) {
  [0]=>
  string(4) "8851"
  ["article_id"]=>
  string(4) "8851"
  [1]=>
  string(106) "Press release Biocartis Group NV: Invitation to the Annual and Extraordinary Shareholders’ Meetings"
  ["article_title"]=>
  string(106) "Press release Biocartis Group NV: Invitation to the Annual and Extraordinary Shareholders’ Meetings"
  [2]=>
  string(238) "PRESS RELEASE: REGULATED INFORMATION7 April 2020, 07:00 CEST                                              "
  ["short_description"]=>
  string(238) "PRESS RELEASE: REGULATED INFORMATION7 April 2020, 07:00 CEST                                              "
  [3]=>
  string(509) "
PRESS RELEASE: REGULATED INFORMATION
7 April 2020, 07:00 CEST
                                                                                                             
"
  ["description"]=>
  string(509) "
PRESS RELEASE: REGULATED INFORMATION
7 April 2020, 07:00 CEST
                                                                                                             
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(168) "http://www.globenewswire.com/news-release/2020/04/07/2012534/0/en/Press-release-Biocartis-Group-NV-Invitation-to-the-Annual-and-Extraordinary-Shareholders-Meetings.html"
  ["blog_url"]=>
  string(168) "http://www.globenewswire.com/news-release/2020/04/07/2012534/0/en/Press-release-Biocartis-Group-NV-Invitation-to-the-Annual-and-Extraordinary-Shareholders-Meetings.html"
  [15]=>
  string(19) "2020-04-07 13:00:00"
  ["add_date"]=>
  string(19) "2020-04-07 13:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Press release Biocartis Group NV: Invitation to the Annual and Extraordinary Shareholders

PRESS RELEASE: REGULATED INFORMATION
7 April 2020, 07:00 CEST
         Â

array(40) {
  [0]=>
  string(4) "8852"
  ["article_id"]=>
  string(4) "8852"
  [1]=>
  string(108) "Persbericht Biocartis Group NV: Oproeping tot de Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen"
  ["article_title"]=>
  string(108) "Persbericht Biocartis Group NV: Oproeping tot de Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen"
  [2]=>
  string(73) "PERSBERICHT: GEREGLEMENTEERDE INFORMATIE            "
  ["short_description"]=>
  string(73) "PERSBERICHT: GEREGLEMENTEERDE INFORMATIE            "
  [3]=>
  string(87) "
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE            
"
  ["description"]=>
  string(87) "
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE            
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(178) "http://www.globenewswire.com/news-release/2020/04/07/2012534/0/nl/Persbericht-Biocartis-Group-NV-Oproeping-tot-de-Gewone-en-Buitengewone-Algemene-Aandeelhoudersvergaderingen.html"
  ["blog_url"]=>
  string(178) "http://www.globenewswire.com/news-release/2020/04/07/2012534/0/nl/Persbericht-Biocartis-Group-NV-Oproeping-tot-de-Gewone-en-Buitengewone-Algemene-Aandeelhoudersvergaderingen.html"
  [15]=>
  string(19) "2020-04-07 13:00:00"
  ["add_date"]=>
  string(19) "2020-04-07 13:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Persbericht Biocartis Group NV: Oproeping tot de Gewone en Buitengewone Algemene Aandeelho

PERSBERICHT: GEREGLEMENTEERDE INFORMATIE            

array(40) {
  [0]=>
  string(4) "8914"
  ["article_id"]=>
  string(4) "8914"
  [1]=>
  string(67) "Podcast: The challenges and opportunities in personalised nutrition"
  ["article_title"]=>
  string(67) "Podcast: The challenges and opportunities in personalised nutrition"
  [2]=>
  string(150) "Miguel Toribio-Mateas, director of nutrition and health research at Atlas Biomed, speaks about the importance of personalised nutrition and citizen sc"
  ["short_description"]=>
  string(150) "Miguel Toribio-Mateas, director of nutrition and health research at Atlas Biomed, speaks about the importance of personalised nutrition and citizen sc"
  [3]=>
  string(268) "Miguel Toribio-Mateas, director of nutrition and health research at Atlas Biomed, speaks about the importance of personalised nutrition and citizen science to the future of nutrition innovation and advises how to utilise this period of quarantine to educate consumers."
  ["description"]=>
  string(268) "Miguel Toribio-Mateas, director of nutrition and health research at Atlas Biomed, speaks about the importance of personalised nutrition and citizen science to the future of nutrition innovation and advises how to utilise this period of quarantine to educate consumers."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(170) "https://www.nutraingredients.com/Article/2020/04/07/Podcast-The-challenges-and-opportunities-in-personalised-nutrition?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(170) "https://www.nutraingredients.com/Article/2020/04/07/Podcast-The-challenges-and-opportunities-in-personalised-nutrition?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-04-07 13:00:00"
  ["add_date"]=>
  string(19) "2020-04-07 13:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:12"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:12"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Podcast: The challenges and opportunities in personalised nutrition

Miguel Toribio-Mateas, director of nutrition and health research at Atlas Biomed, speaks about the importance of persona

array(40) {
  [0]=>
  string(4) "8830"
  ["article_id"]=>
  string(4) "8830"
  [1]=>
  string(59) "Gilead Ramps Up Remdesivir Production as More Trials Emerge"
  ["article_title"]=>
  string(59) "Gilead Ramps Up Remdesivir Production as More Trials Emerge"
  [2]=>
  string(158) "&#nl        Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesivir for COVID-19 and hopes to have 500,"
  ["short_description"]=>
  string(158) "&#nl        Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesivir for COVID-19 and hopes to have 500,"
  [3]=>
  string(267) "&#nl        Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesivir for COVID-19 and hopes to have 500,000 treatment courses by October, and more than 1 million treatment courses by the end of the year.&#nl      "
  ["description"]=>
  string(267) "&#nl        Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesivir for COVID-19 and hopes to have 500,000 treatment courses by October, and more than 1 million treatment courses by the end of the year.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(99) "https://www.fdanews.com/articles/196541-gilead-ramps-up-remdesivir-production-as-more-trials-emerge"
  ["blog_url"]=>
  string(99) "https://www.fdanews.com/articles/196541-gilead-ramps-up-remdesivir-production-as-more-trials-emerge"
  [15]=>
  string(19) "2020-04-07 12:01:00"
  ["add_date"]=>
  string(19) "2020-04-07 12:01:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:46"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Gilead Ramps Up Remdesivir Production as More Trials Emerge

&#nl Gilead CEO Daniel O’Day announced that the company is ramping up production of its antiviral remdesiv

array(40) {
  [0]=>
  string(4) "8831"
  ["article_id"]=>
  string(4) "8831"
  [1]=>
  string(50) "Inovio Initiates Phase 1 Trial of COVID-19 Vaccine"
  ["article_title"]=>
  string(50) "Inovio Initiates Phase 1 Trial of COVID-19 Vaccine"
  [2]=>
  string(158) "&#nl        Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, cleari"
  ["short_description"]=>
  string(158) "&#nl        Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, cleari"
  [3]=>
  string(200) "&#nl        Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, clearing the way for a clinical trial.&#nl      "
  ["description"]=>
  string(200) "&#nl        Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID-19 vaccine candidate INO-4800, clearing the way for a clinical trial.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(90) "https://www.fdanews.com/articles/196540-inovio-initiates-phase-1-trial-of-covid-19-vaccine"
  ["blog_url"]=>
  string(90) "https://www.fdanews.com/articles/196540-inovio-initiates-phase-1-trial-of-covid-19-vaccine"
  [15]=>
  string(19) "2020-04-07 12:00:00"
  ["add_date"]=>
  string(19) "2020-04-07 12:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:46"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:46"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}

Inovio Initiates Phase 1 Trial of COVID-19 Vaccine

&#nl Inovio announced yesterday that the FDA signed off on the company’s investigational NDA for its COVID